Celastrol prevents cadmium-induced neuronal cell death via targeting JNK and PTEN-Akt/mTOR network

Sujuan Chen1, Chenjian Gu1, Chong Xu1

  • 1Jiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China.

Journal of Neurochemistry
|October 12, 2013
PubMed

Insights

Celastrol, a plant compound, protects neurons from cadmium toxicity by inhibiting JNK and activating the PTEN-Akt/mTOR pathway. This suggests celastrol could prevent neurodegenerative disorders caused by cadmium exposure.

Area of Science:

  • Neuroscience
  • Toxicology
  • Pharmacology

Background:

  • Cadmium (Cd) is a toxic environmental contaminant linked to neurodegenerative diseases.
  • Celastrol, a plant-derived triterpene, exhibits neuroprotective properties.
  • The specific effects of celastrol on cadmium-induced neurotoxicity remain largely unexplored.

Purpose of the Study:

  • To investigate the protective effects of celastrol against cadmium-induced neurotoxicity in neuronal cells.
  • To elucidate the molecular mechanisms underlying celastrol's neuroprotective action in the context of cadmium exposure.
  • To assess the potential of celastrol as a therapeutic agent for cadmium-induced neurodegenerative disorders.

Main Methods:

  • Neuronal cell cultures were exposed to cadmium, with or without celastrol pre-treatment.
  • Cell viability, apoptosis markers (caspase-3 activation, nuclear fragmentation), and signaling pathways (JNK, PTEN, Akt, mTOR) were assessed.
  • Specific inhibitors (SP600125) and genetic manipulations (dominant-negative c-Jun, wild-type PTEN) were employed to dissect signaling pathways.

Main Results:

  • Celastrol significantly attenuated cadmium-induced neuronal cell death, reducing apoptosis and morphological damage.
  • Celastrol inhibited cadmium-induced c-Jun N-terminal kinase (JNK) phosphorylation.
  • Celastrol prevented cadmium-induced down-regulation of PTEN and subsequent activation of the Akt/mTOR pathway.

Conclusions:

  • Celastrol confers neuroprotection against cadmium toxicity by inhibiting JNK activation and modulating the PTEN-Akt/mTOR signaling network.
  • Celastrol's mechanism involves up-regulating PTEN, which suppresses the pro-survival Akt/mTOR pathway.
  • These findings highlight celastrol as a promising candidate for preventing cadmium-induced neurodegenerative diseases.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.4K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
11.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.2K